e-learning
resources
Vienna 2003
Sunday 28.09.2003
Mesothelioma and malignant effusions
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pleural fluid, serum β-HCG levels and pleural fluid/serum β-HCG ratio for the discrimination of malignant and benign pleural effusions
F. Ugurman, A. Gozu, G. Onde Ucoluk, B. Akkalyoncu, S. Yordam, B. Samurkasoglu (Ankara, Turkey)
Source:
Annual Congress 2003 - Mesothelioma and malignant effusions
Session:
Mesothelioma and malignant effusions
Session type:
Thematic Poster Session
Number:
488
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Ugurman, A. Gozu, G. Onde Ucoluk, B. Akkalyoncu, S. Yordam, B. Samurkasoglu (Ankara, Turkey). Pleural fluid, serum β-HCG levels and pleural fluid/serum β-HCG ratio for the discrimination of malignant and benign pleural effusions. Eur Respir J 2003; 22: Suppl. 45, 488
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of solitary fibrous tumours of the pleura: a systematic review and meta-analysis
Utility of pleural fluid for predictive marker testing in malignant pleural effusion
Diagnosis and staging of malignant pleural mesothelioma
Related content which might interest you:
Accuracy of pleural fluid c-reactive protein in differentiating between tuberculous and malignant pleural effusions: a meta-analysis
Source: International Congress 2019 – Tuberculosis and comorbidities
Year: 2019
Correlation between pleural fluid cytological yield and pleural tumour burden in malignant pleural effusions
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010
Pleural fluid procalcitonin levels in identifying pleural effusions due to infection
Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections
Year: 2009
Value of pleural fluid and serum NT-ProBNP levels in differentiation of transudative and exudative pleural effusions
Source: Annual Congress 2010 - Novel approach in diagnosis and treatment of pleural effusions
Year: 2010
Pleural fluid leptin level for the differential diagnosis of pleural effusion
Source: Eur Respir J 2006; 28: Suppl. 50, 343s
Year: 2006
Is it important to determine pleural fluid amylase in patients with malignant pleural effusions?
Source: Eur Respir J 2007; 30: Suppl. 51, 565s
Year: 2007
Cytology of pleural fluid versus histopathology of the pleura in the diagnosis of malignant pleural effusions
Source: Eur Respir J 2006; 28: Suppl. 50, 775s
Year: 2006
The diagnostic value of pleural fluid C-reactive protein level in pleural effusions
Source: Eur Respir J 2002; 20: Suppl. 38, 356s
Year: 2002
Predictors of trapped lung in patients with malignant pleural effusions; comparison of pleural elastance and pleural fluid pH
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009
Usefulness of pleural fluid C-reactive protein in differentiation of pleural effusions
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009
Usefulness of pleural fluid C-reactive protein in differentiation of pleural effusions
Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges
Year: 2010
Transudative malignant pleural effusions
Source: International Congress 2019 – Novel approaches to pleural effusion: should I change my practice?
Year: 2019
Utility of pleural fluid glucose measurement in TB pleural effusions.
Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis
Year: 2020
Comparison and relationship of cholesterol and lipoproteins of pleural effusions with serum levels of them in exudative and transudative pleural fluid
Source: Eur Respir J 2005; 26: Suppl. 49, 446s
Year: 2005
Diagnostic approach in a patient with pleural effusion
Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=131
Year: 2002
Lymphocytic pleural effusion. Can ADA levels in pleural fluid exclude malignancy?
Source: Eur Respir J 2006; 28: Suppl. 50, 783s
Year: 2006
Evaluation of pleural fluid human epididymis 4 (HE4) as a marker of malignant pleural effusions
Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions
Year: 2012
Pleural fluid IL-6 levels in the identification of the complicated parapneumonic pleural effusion
Source: Annual Congress 2008 - Pleural effusion
Year: 2008
Correlation between pleural fluid and serum C-reactive protein in patients with pleural effusion due to different etiologies
Source: Virtual Congress 2020 – Interesting clinical problems for the respiratory physician
Year: 2020
Utility of pleural fluid for predictive marker testing in malignant pleural effusion
Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept